申请人:Chung Kwang Hoe
公开号:US20100120849A1
公开(公告)日:2010-05-13
The present invention relates to a pharmaceutical composition for preventing or treating hyperproliferative vascular disorders, and a pharmaceutical anticancer composition comprising the compound represented by the Formula 1. The present compounds exhibit IC
50
values of less than 0.16 μM for vascular smooth muscle cells and cancer cells to effectively prevent proliferation of vascular smooth muscle cells and cancer cells, thereby ensuring prevention or treatment of hyperproliferative vascular disorders such as arteriosclerosis and restenosis, and cancers.
本发明涉及一种用于预防或治疗高增殖性血管疾病的药物组合物,以及包含由化合物代表的化合物的药用抗癌组合物1。目前的化合物对血管平滑肌细胞和癌细胞的IC50值小于0.16μM,有效地预防了血管平滑肌细胞和癌细胞的增殖,从而确保预防或治疗如动脉粥样硬化和再狭窄等高增殖性血管疾病和癌症。